Cargando…

Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution

Jumping translocations are uncommon cytogenetic abnormalities in which a segment of a donor chromosome, often 1q, is transferred to two or more receptor chromosomes. We describe the case of a 64-year-old man with a history of acute myeloid leukemia associated with myelodysplastic syndrome, who prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez Prieto, Irene, López Rubio, Montserrat, Arranz, Eva, Ayala, Rosa, Callejas Charavía, Marta, Martín Guerrero, Yolanda, Gil Fernández, Juan José, Valenciano Martínez, Susana, Castilla García, Lucía, Argüello Marina, María, Aspa Cilleruelo, José María, Martínez Vázquez, Celia, García Suárez, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548953/
https://www.ncbi.nlm.nih.gov/pubmed/33082743
http://dx.doi.org/10.1159/000508999
Descripción
Sumario:Jumping translocations are uncommon cytogenetic abnormalities in which a segment of a donor chromosome, often 1q, is transferred to two or more receptor chromosomes. We describe the case of a 64-year-old man with a history of acute myeloid leukemia associated with myelodysplastic syndrome, who presented with a relapse of the leukemia and, concomitantly, with the appearance of a jumping translocation involving chromosome 1q. The patient had a poor clinical course without the possibility of performing targeted treatment, and he died 5 months after relapse. Jumping translocations are a reflection of chromosomal instability, and they could be related to epigenetic alterations such as pericentromeric chromatin hypomethylation, telomere shortening, or pathogenic variants of the TP53 gene. The existing data suggests a poor clinical outcome, a high risk of disease progression, and an unfavorable prognosis. More molecular studies are required to gain an in-depth understanding of the genetic mechanism underlying these alterations and their clinical significance and to be able to apply an optimal treatment to patients.